252 related articles for article (PubMed ID: 18042431)
1. How does HTLV-I persist despite a strong cell-mediated immune response?
Asquith B; Bangham CR
Trends Immunol; 2008 Jan; 29(1):4-11. PubMed ID: 18042431
[TBL] [Abstract][Full Text] [Related]
2. Human T-lymphotropic virus type 1 (HTLV-1) and cellular immune response in HTLV-1-associated myelopathy/tropical spastic paraparesis.
Nozuma S; Kubota R; Jacobson S
J Neurovirol; 2020 Oct; 26(5):652-663. PubMed ID: 32705480
[TBL] [Abstract][Full Text] [Related]
3. HTLV-1 drives vigorous clonal expansion of infected CD8(+) T cells in natural infection.
Melamed A; Laydon DJ; Al Khatib H; Rowan AG; Taylor GP; Bangham CR
Retrovirology; 2015 Nov; 12():91. PubMed ID: 26552867
[TBL] [Abstract][Full Text] [Related]
4. The immune response to HTLV-I.
Bangham CR
Curr Opin Immunol; 2000 Aug; 12(4):397-402. PubMed ID: 10899027
[TBL] [Abstract][Full Text] [Related]
5. Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+ T cells: immunodominance hierarchy and preferential infection with HTLV-I.
Goon PK; Igakura T; Hanon E; Mosley AJ; Barfield A; Barnard AL; Kaftantzi L; Tanaka Y; Taylor GP; Weber JN; Bangham CR
J Immunol; 2004 Feb; 172(3):1735-43. PubMed ID: 14734756
[TBL] [Abstract][Full Text] [Related]
6. Cell-mediated immune response to human T-lymphotropic virus type I.
Mosley AJ; Asquith B; Bangham CR
Viral Immunol; 2005; 18(2):293-305. PubMed ID: 16035941
[TBL] [Abstract][Full Text] [Related]
7. HTLV-1: persistence and pathogenesis.
Cook LB; Elemans M; Rowan AG; Asquith B
Virology; 2013 Jan; 435(1):131-40. PubMed ID: 23217623
[No Abstract] [Full Text] [Related]
8. Neuroimmunity of HTLV-I Infection.
Matsuura E; Yamano Y; Jacobson S
J Neuroimmune Pharmacol; 2010 Sep; 5(3):310-25. PubMed ID: 20437106
[TBL] [Abstract][Full Text] [Related]
9. The immune control and cell-to-cell spread of human T-lymphotropic virus type 1.
Bangham CRM
J Gen Virol; 2003 Dec; 84(Pt 12):3177-3189. PubMed ID: 14645900
[TBL] [Abstract][Full Text] [Related]
10. Degenerate specificity of HTLV-1-specific CD8+ T cells during viral replication in patients with HTLV-1-associated myelopathy (HAM/TSP).
Kubota R; Furukawa Y; Izumo S; Usuku K; Osame M
Blood; 2003 Apr; 101(8):3074-81. PubMed ID: 12480698
[TBL] [Abstract][Full Text] [Related]
11. Direct evidence for a chronic CD8+-T-cell-mediated immune reaction to tax within the muscle of a human T-cell leukemia/lymphoma virus type 1-infected patient with sporadic inclusion body myositis.
Ozden S; Cochet M; Mikol J; Teixeira A; Gessain A; Pique C
J Virol; 2004 Oct; 78(19):10320-7. PubMed ID: 15367598
[TBL] [Abstract][Full Text] [Related]
12. The role of CTLs in persistent viral infection: cytolytic gene expression in CD8+ lymphocytes distinguishes between individuals with a high or low proviral load of human T cell lymphotropic virus type 1.
Vine AM; Heaps AG; Kaftantzi L; Mosley A; Asquith B; Witkover A; Thompson G; Saito M; Goon PK; Carr L; Martinez-Murillo F; Taylor GP; Bangham CR
J Immunol; 2004 Oct; 173(8):5121-9. PubMed ID: 15470056
[TBL] [Abstract][Full Text] [Related]
13. Activated, HTLV-1-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis.
Parker CE; Daenke S; Nightingale S; Bangham CR
Virology; 1992 Jun; 188(2):628-36. PubMed ID: 1374983
[TBL] [Abstract][Full Text] [Related]
14. The immune control of HTLV-1 infection: selection forces and dynamics.
Bangham CR; Meekings K; Toulza F; Nejmeddine M; Majorovits E; Asquith B; Taylor GP
Front Biosci (Landmark Ed); 2009 Jan; 14(8):2889-903. PubMed ID: 19273242
[TBL] [Abstract][Full Text] [Related]
15. Cellular immune response to HTLV-1.
Bangham CR; Osame M
Oncogene; 2005 Sep; 24(39):6035-46. PubMed ID: 16155610
[TBL] [Abstract][Full Text] [Related]
16. Genetic control and dynamics of the cellular immune response to the human T-cell leukaemia virus, HTLV-I.
Bangham CR; Hall SE; Jeffery KJ; Vine AM; Witkover A; Nowak MA; Wodarz D; Usuku K; Osame M
Philos Trans R Soc Lond B Biol Sci; 1999 Apr; 354(1384):691-700. PubMed ID: 10365395
[TBL] [Abstract][Full Text] [Related]
17. Expansion of human T-cell leukemia virus type 1 (HTLV-1) reservoir in orally infected rats: inverse correlation with HTLV-1-specific cellular immune response.
Hasegawa A; Ohashi T; Hanabuchi S; Kato H; Takemura F; Masuda T; Kannagi M
J Virol; 2003 Mar; 77(5):2956-63. PubMed ID: 12584320
[TBL] [Abstract][Full Text] [Related]
18. Quantifying HTLV-I dynamics.
Asquith B; Bangham CR
Immunol Cell Biol; 2007 Jun; 85(4):280-6. PubMed ID: 17372609
[TBL] [Abstract][Full Text] [Related]
19. The frequency of CD127low expressing CD4+CD25high T regulatory cells is inversely correlated with human T lymphotrophic virus type-1 (HTLV-1) proviral load in HTLV-1-infection and HTLV-1-associated myelopathy/tropical spastic paraparesis.
Michaëlsson J; Barbosa HM; Jordan KA; Chapman JM; Brunialti MK; Neto WK; Nukui Y; Sabino EC; Chieia MA; Oliveira AS; Nixon DF; Kallas EG
BMC Immunol; 2008 Jul; 9():41. PubMed ID: 18664281
[TBL] [Abstract][Full Text] [Related]
20. Status of humoral and cellular immune markers in human T-cell lymphotropic virus type 1 (HTLV-1) asymptomatic carriers in northeastern Iran, Mashhad.
Hedayati-Moghaddam MR; Mollahosseini F; Namazi MJ; Mosavat A; Rezaee SA; Mahdifar M; Bidkhori HR; Valizadeh N; Rafatpanah H
J Neurovirol; 2020 Dec; 26(6):863-869. PubMed ID: 33025348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
